Free equity investment tool of Japanese companies

Credit Rating Analysis

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

SmartEbook.com.

青山財産ネットワークス

ゴルフダイジェスト・オンライン

NIHONWASOU HOLDINGS

オリジナル設計

T&C HOLDINGS

Nippon RAD

シダー

デジタルデザイン

OncoTherapy Science

Fund Creation Group

デジタルアドベンチャー

キャリアバンク

トライアイズ

System Technology-i

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

NITCHITSU　

Nissan Motor

NIPPON COKE & ENGINEERING

Yushiro Chemical Indutry

日本アビオニクス

Credit Rating Analysis: OncoTherapy Science (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

Credit Rating (Bankruptcy Risk): OncoTherapy Science (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-03-31	BB	Credit is a little enough, but be insufficient potential by biz environs.	¥ 3 B -47.34%	¥ -1 B -188.68%	¥ -1 B -251.92%

Financial Timeline

Date	2012-12-31  (Third quarter )	2013-03-31  (Annual )	2013-06-30  (First quarter )	2013-09-30  (Second quarter )
Credit Rating	BB	BB	BB	BB
Total Assets	¥ 10 B	¥ 11 B	¥ 10 B	¥ 20 B
Net Assets	¥ 9 B	¥ 10 B	¥ 9 B	¥ 19 B

Financial Statement Risk Analysis: OncoTherapy Science (Annual ) (Consolidated )

Special note

Cash(¥ 8 B) is more than the total liabilities(¥ 1 B). It is a very steady fiscal base!

[Date: 2013-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income & Operating Cash Flow is minus or 0 )
Net Income(¥ -1 B) & Operating Cash Flow (¥ -455 M) is minus or 0, so , there is a possibility that the management situation is very severe.

Management Risk (*Sales is decrease )
Sales (¥ 3 B) is first term Sales (¥ 6 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Income is decrease )
Net Income (¥ -1 B) is first term Net Income (¥ 726 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-33.66％) is first term Net Profit Margin (11.67％) less , there is a possibility that the profitability has deteriorated.

Financing Risk (*Financial Cash Flow is plus )
Operating Cash Flow (¥ -455 M) is a minus, Financial Cash Flow (¥ 24 M) is a plus. Because sale is inactive, it may depend for financing on loan from banks, capital increase, etc.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ -586 M) is Sales first term ratio (¥ -2 B) more , there is a possibility that the non-performing asset was increased.

Overinvestment Risk (*Intangible Assets confirmed content)
Operating Cash Flow (¥ -455 M) and Investment Cash Flow (¥ -9 M) is minus, so , there is a possibility of the overinvestment.

[Date: 2012-03-31]  Danger : Warning : Caution : Good

Financing Risk (*Issuance of new shares)
Investment Cash Flow (¥ 3 B) is a plus, Issuance of new shares (¥ 27 M) is plus. Because it is thought that the circulating fund is gained by sale and new issue of stocks of stock property , there is a possibility that the financing is severe.

Financing Risk (*Financial Cash Flow is plus )
Operating Cash Flow (¥ -91 M) is a minus, Financial Cash Flow (¥ 25 M) is a plus. Because sale is inactive, it may depend for financing on loan from banks, capital increase, etc.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 6 B) is first term (¥ 5 B) more, however Operating Cash Flow (¥ -91 M) is first term (¥ 440 M) less , there is a possibility that the financing has deteriorated very much.

Financing Risk (*Sale of stock property)
Operating Cash Flow (¥ -91 M) is minus, Investment Cash Flow (¥ 3 B) is plus. Because the main occupation was dull, stock property may have been sold off.

[Date: 2011-03-31]  Danger : Warning : Caution : Good

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 5 B) is first term (-) more, however Operating Cash Flow (¥ 440 M) is first term (¥ 1 B) less , there is a possibility that the financing has deteriorated very much.

[Date: 2010-03-31]  Danger : Warning : Caution : Good

Management Risk (*Gross Income is decrease )
Gross Income (¥ -620 M) is first term Gross Income (¥ -384 M) less , there is a possibility that the management situation has stagnated and deteriorated

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 261 M) is Sales first term ratio (-) more , there is a possibility that the non-performing asset was increased.

[Date: 2009-03-31]  Danger : Warning : Caution : Good

Financing Risk (*Issuance of new shares)
Financial Cash Flow (¥ -91 M) is a minus, Issuance of new shares (¥ 19 M) is plus. Because a possibility of having appropriated the capital-increase fund for repayment of borrowed money is high , there is a possibility that the financing is extremely severe.

Financing Risk (*Issuance of new shares)
Investment Cash Flow (¥ 5 B) is a plus, Issuance of new shares (¥ 19 M) is plus. Because it is thought that the circulating fund is gained by sale and new issue of stocks of stock property , there is a possibility that the financing is severe.

Financing Risk (*Sale of stock property)
Operating Cash Flow (¥ -223 M) is minus, Investment Cash Flow (¥ 5 B) is plus. Because the main occupation was dull, stock property may have been sold off.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets (¥ 596 M) is Operating Cash Flow (¥ -223 M) is a minus, Sales (-) more , there is a possibility of holding the non-performing asset.

Credit Rating (Bankruptcy Risk): OncoTherapy Science (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-03-31	BBB	Credit is enough, but be decreased potential by biz environs.	¥ 3 B -45.94%	¥ -1 B -186.57%	¥ -1 B -240.93%

Financial Timeline

Date	-  (First quarter )	-  (Second quarter )	-  (Third quarter )	2013-03-31  (Annual )
Credit Rating	-	-	-	BBB
Total Assets	-	-	-	¥ 11 B
Net Assets	-	-	-	¥ 10 B

Financial Statement Risk Analysis: OncoTherapy Science (Annual ) (Non-Consolidated )

Special note

Cash(¥ 8 B) is more than the total liabilities(¥ 1 B). It is a very steady fiscal base!

[Date: 2013-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income & Sales is sharp decrease )
As compared with the first term of Sales (¥ 3 B) , Sales (¥ 6 B) is less than 80%, and As compared with the first term of Net Income (¥ 745 M) , Net Income (¥ -1 B) is less than 10%, , there is a possibility that the management situation has deteriorated very much.

Management Risk (*Sales is decrease )
Sales (¥ 3 B) is first term Sales (¥ 6 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Income is decrease )
Net Income (¥ -1 B) is first term Net Income (¥ 745 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-32.04％) is first term Net Profit Margin (12.29％) less , there is a possibility that the profitability has deteriorated.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ -580 M) is Sales first term ratio (¥ -2 B) more , there is a possibility that the non-performing asset was increased.

[Date: 2012-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is decrease )
Net Income (¥ 745 M) is first term Net Income (¥ 804 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (12.29％) is first term Net Profit Margin (15.00％) less , there is a possibility that the profitability has deteriorated.

[Date: 2011-03-31]

*Financial Statement Risk was not found.

[Date: 2010-03-31]  Danger : Warning : Caution : Good

Management Risk (*Gross Income is decrease )
Gross Income (¥ -571 M) is first term Gross Income (¥ -448 M) less , there is a possibility that the management situation has stagnated and deteriorated

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 253 M) is Sales first term ratio (-) more , there is a possibility that the non-performing asset was increased.

[Date: 2009-03-31]

*Financial Statement Risk was not found.

Related Information: OncoTherapy Science (Annual )

Statement Type

Annual : OncoTherapy Science

First quarter : OncoTherapy Science

Second quarter : OncoTherapy Science

Third quarter : OncoTherapy Science

Analysis Menu

Outline : OncoTherapy Science

Statement : OncoTherapy Science

Rating : OncoTherapy Science

Indicator : OncoTherapy Science

Download : OncoTherapy Science

Industry Comparison Ranking

Other Services - EDIUNET Industry Rankings

Other Services - EDIUNET Credit Rating

Other Services - EDIUNET Industry Avg

Comparison with a neighboring company

Kanagawa - EDIUNET Prefectures

Kanagawa川崎市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/21	Netindex.	CC	2013-11-30
1/20	川崎地質	BB→BBB	2013-11-30
1/20	KYOWA ENGINEERING CONSU..	B→BB	2013-11-30
1/20	KG Intelligence	AAA→AA	2013-12-20
1/16	アクトコール	-→B	2013-11-30
1/16	S-Pool	C→CC	2013-11-30
1/16	T&C HOLDINGS	C	2013-11-30
1/15	HITO	-→AAA	2013-11-30 (Q1)
1/15	Pasona Group	CC	2013-11-30 (Q2)
1/15	乃村工藝社	BB→BBB	2013-11-30 (Q3)

EDIUNET Investment News (Other Services)

1/21 Other Services (Netindex.:CC)

1/20 Other Services (川崎地質:BB→..

1/16 Other Services (アクトコール..

1/15 Other Services (HITO:-→AAA e..

1/10 Other Services (JASTEC:BB→BB..

1/9 Other Services (MEIKO NETWOR..

1/7 Other Services (ジェイコム:A..

1/6 Other Services (ダイヤモンド..

12/27 Other Services (D Wonderland..

12/26 Other Services (キャリアリン..

Company Information

Ticker	Market	Industry	Month	report	Rating
OncoTherapy Science	4564	TSE Mothers	Other Services	3	Annual	BB

Related Company

T&C HOLDINGS (Sales ¥ 481 M)

Full Speed (Sales ¥ 10 B)

アクトコール (Sales ¥ 1 B)

SmartEbook.com. (Sales ¥ 450 M)

Nextware (Sales ¥ 2 B)

e-Seikatsu (Sales ¥ 1 B)

RUDEN HOLDINGS (Sales ¥ 2 B)

Fund Creation Group (Sales ¥ 745 M)

System Technology-i (Sales ¥ 892 M)

ODAWARA AUTO-MACHINE MFG. (Sales ¥ 2 B)

トライアイズ (Sales ¥ 5 B)

NIHONWASOU HOLDINGS (Sales ¥ 5 B)

AIREX. (Sales ¥ 3 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .